Auro Peptides Limited - Company Profile

It is a pharma public limited company based in Hyderabad, Telangana, India, established in 2012.
2012 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Auro Peptides Limited

Auro Peptides Limited, a active public limited company, was established on 02 January 2012 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232TG2012PLC078350. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹450.10 Cr and a paid-up capital of ₹336.10 Cr.

It upholds a compliant status. Employing 169 professional, Its leadership includes Sivakumaran Meenakshisunderam (Director), Mudiraj Saritha Rani (Director), Chandra Reddy Tirumalareddy (Whole-Time Director). Past directors included Vinod Kumar Reddy Aerva, Singhal Shilpa, Govindarajan Narayanan. Its latest AGM occurred on 01 September 2025, with the balance sheet filed on 31 March 2025. It is based at Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1 Hyderabad Knowledge City, Raidurg Panmak, Tha, Hyderabad, Telangana, 500032.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232TG2012PLC078350

  • Registration Number

    078350

  • Incorporation Date

    02 January 2012

  • Authorized Capital

    ₹450.10 Cr

  • Paid-Up Capital

    ₹336.10 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 450.10 Cr
  • Paid Up Capital ₹ 336.10 Cr
  • Company Age 14 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 141.42%
  • Profit Growth **** 58.63%
  • Ebitda **** 126.53%
  • Net Worth -10.32%
  • Total Assets **** 58.18%
Company report

Auro Peptides Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Auro Peptides Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Auro Peptides Limited?
Current Directors
Name Designation Appointment Date Status
Sivakumaran Meenakshisunderam Director 29 Sep 2017 Current
Mudiraj Saritha Rani Director 15 Jun 2022 Current
Chandra Reddy Tirumalareddy Whole-Time Director 23 May 2019 Current
Mylandlahalli Rammohan Ashwini Additional Director 30 Oct 2025 Current
Satakarni Makkapati Director 02 Nov 2021 Current
Naga Venkata Subbarao Kesavarapu Director 20 Jan 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 15 Jun 2022 Past
Pramod Abcsdd Director 10 Nov 2022 Past
Pramod Abcsdd Director 29 Sep 2017 Past
Pramod Abcsdd Director 02 Nov 2021 Past
Pramod Abcsdd Additional Director 27 Aug 2018 Past
Pramod Abcsdd Additional Director 20 Jun 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Auro Peptides.

Auro Peptides Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 141.42% increase. The company also saw a substantial improvement in profitability, with a 58.63% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.32%.

Auro Peptides revenue growth over time
Auro Peptides profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 141.42%
*******
*******
*******
*******
Revenue from Operations
*******
 141.18%
*******
*******
*******
*******
Total Assets
*******
 58.18%
*******
*******
*******
*******
Profit or Loss
*******
 58.63%
*******
*******
*******
*******
Net Worth
*******
 -10.32%
*******
*******
*******
*******
EBITDA
*******
 126.53%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Auro Peptides?

In 2023, Auro Peptides had a promoter holding of 95.00% and a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Auro Peptides?

Auro Peptides has a workforce of 169 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Auro Peptides, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Auro Peptides's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Auro Peptides
Recent Activity within the Organization
  • Director Appointment

    Mylandlahalli Rammohan Ashwini was appointed as a Additional Director was appointed as a Additional Director on 30 Oct 2025 & has been associated with this company since 3 months 13 days . was recorded as a recent event.

  • Director Appointment

    Progress on Rajendra Rekapu Krishna was appointed as a Additional Director was appointed as a Additional Director on 30 Oct 2025 & has been associated with this company since 3 months 13 days . was documented.

  • Annual General Meeting

    Auro Peptides Limited last Annual general meeting of members was held on 01 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Auro Peptides Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.

  • Director Appointment

    Progress on Kadapa Gandla Sunanda was appointed as a Company Secretary was appointed as a Company Secretary on 27 Aug 2024 & has been associated with this company since 1 year 5 months . was documented.

  • Director Appointment

    Mylandlahalli Rammohan Ashwini was appointed as a Cfo was appointed as a Cfo on 21 Mar 2024 & has been associated with this company since 1 year 10 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Auro Peptides Limited?

The CIN of Auro Peptides Limited is U24232TG2012PLC078350.

Where is Auro Peptides Limited headquartered?

Auro Peptides Limited is headquartered at Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1 Hyderabad Knowledge City, Raidurg Panmak, Tha, Hyderabad, Telangana, 500032.

When was Auro Peptides Limited incorporated?

Auro Peptides Limited was incorporated on 02 January 2012.

Who are the current directors of Auro Peptides Limited?

The current directors of Auro Peptides Limited are

What is the primary industry of Auro Peptides Limited?

The primary industry of Auro Peptides Limited is Manufacturing.

Is Auro Peptides Limited a listed company?

Auro Peptides Limited is unlisted.

What is the capital structure of Auro Peptides Limited?

The authorized capital of Auro Peptides Limited is ₹450.10 Cr, and the paid-up capital is ₹336.10 Cr.

What is the compliance status of Auro Peptides Limited?

The compliance status of Auro Peptides Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available